Anatomopathological analysis of sentinel and nonsentinel lymph nodes in breast cancer: Hematoxylin-eosin versus immunohistochemistry

International Journal of Surgical Pathology

Volumn 15, Issue 4, 2007, Pages 358-368

  Teixeira Soares, Cleverson ^a   Frederigue Jr , Ulisses ^b   De Luca, Laurival Antonio ^c  

^a INSTITUTO LAURO DE SOUZA LIMA   (Brazil)

^b Instituto de Anatomia Patológica de Bauru   (Brazil)

^c SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Immunohistochemistry; Metastasis; Sentinel lymph node

Indexed keywords

EOSIN; HEMATOXYLIN;

ADULT; AGED; ARTICLE; BREAST CANCER; BREAST CARCINOMA; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOLOGY; DIAGNOSTIC ACCURACY; FROZEN SECTION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTERMETHOD COMPARISON; LYMPH NODE; LYMPH NODE METASTASIS; PATHOLOGICAL ANATOMY; PREDICTION; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SENTINEL LYMPH NODE; SMEAR; STAINING; TISSUE SLICE;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; AXILLA; BREAST NEOPLASMS; COLORING AGENTS; EOSINE YELLOWISH-(YS); FEMALE; FROZEN SECTIONS; HEMATOXYLIN; HUMANS; IMMUNOHISTOCHEMISTRY; INTRAOPERATIVE PERIOD; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; SENTINEL LYMPH NODE BIOPSY; STAINING AND LABELING;

EID: 34748914342     PISSN: 10668969     EISSN: None     Source Type: Journal    
DOI: 10.1177/1066896907302124     Document Type: Article

References (72)

1. Allweis TM, Badriyyah M., Bar Ad V., et al. Current controversies in sentinel lymph node biopsy for breast cancer. Breast. 2003 ;12(3): 163-171.
2. Cserni G., Amendoeira I., Apostolikas N., et al. Pathological work-up of sentinel lymph nodes in breast cancer: review of current data to be considered for the formulation of guidelines. Eur J Cancer. 2003 ; 39 (12). 1654-1667.
3. Schwartz GF Clinical practice guidelines for the use of axillary sentinel lymph node biopsy in carcinoma of the breast: current update. Breast J. 2004 ; 10 (2). 85-88.
4. Clayton F., Hopkins CL Pathologic correlates of prognosis in lymph node-positive breast carcinomas. Cancer. 1993 ; 71 (5). 1780-1790.
5. Hortobagyi GN Treatment of breast cancer. N Engl J Med. 1998 ; 339 (14). 974-984.
6. Rosen PP, Saigo PE, Braun DW, et al. Axillary micro- and macrometastases in breast cancer: prognostic significance of tumor size. Ann Surg. 1981 ; 194 (5). 585-591.
7. Tanis PJ, Nieweg OE, Olmos Rav, et al. Anatomy and physiology of lymphatic drainage of the breast from the perspective of sentinel node biopsy. J Am Coll Surg. 2001 ; 192 (3). 399-409.
8. Giuliano AE, Kirgan DM, Guenther JM, et al. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg. 1994 ; 220 (3). 391-401.
9. Krag D., Weaver D., Ashikaga T., et al. The sentinel node in breast cancer: a multicenter validation study. N Engl J Med. 1998 ; 339 (14). 941-946.
10. Wells CA, Heryet J., Brochier J., et al. The immunocytochemical detection of axillary micrometastases in breast cancer. Br J Cancer. 1984 ; 50 (2). 193-197.
11. Chu KU, Turner RR, Hansen NM, et al. Sentinel node metastasis in patients with breast carcinoma accurately predicts immunohistochemically detectable nonsentinel node metastasis. Ann Surg Oncol. 1999 ; 6 (8). 756-761.
12. King TA, Ganaraj A., Fey JV, et al. Cytokeratin-positive cells in sentinel lymph nodes in breast cancer are not random events: experience in patients undergoing prophylactic mastectomy. Cancer. 2004 ; 101 (5). 926-933.
13. Moore KH, Thaler HT, Tan LK, et al. Immunohistochemically detected tumor cells in the sentinel lymph nodes of patients with breast carcinoma: biological metastasis or procedural artifact? Cancer. 2004 ; 100 (5). 929-934.
14. Trojani M., de Mascarel I., Bonichon F., et al. Micrometastases to axillary lymph nodes from carcinoma of breast: detection by immunohistochemistry and prognostic significance. Br J Cancer. 1987 ; 55 (6). 303-306.
15. Wong SL, Chao C., Edwards MJ, et al. The use of cytokeratin staining in sentinel lymph node biopsy for breast cancer. Am J Surg. 2001 ; 182 (4). 330-334.
16. Zhang PJ, Reisner RM, Nangia R., et al. Effectiveness of multiple-level sectioning in detecting axillary nodal micrometastasis in breast cancer. Arch Pathol Lab Med. 1998 ; 122 (8). 687-690.
17. Barranger E., Antonine M., Grahek D., et al. Intraoperative imprint cytology of sentinel nodes in breast cancer. J Surg Oncol. 2004 ; 86 (3). 128-133.
18. Chao C. The use of frozen section and immunohistochemistry for sentinel lymph node biopsy in breast cancer. Am Surg. 2004 ; 70 (5). 414-419.
19. Cox C., Centeno B., Dickson D., et al. Accuracy of intraoperative imprint cytology for sentinel lymph node evaluation in the treatment of breast carcinoma. Cancer. 2005 ; 105 (1). 13-20.
20. Creager AJ, Geisinger KR Intraoperative evaluation of sentinel lymph nodes for breast carcinoma: current methodologies. Adv Anat Pathol. 2002 ; 9 (4). 233-243.
21. Cserni G. The potential value of intraoperative imprint cytology of axillary sentinel lymph nodes in breast cancer patients. Am Surg. 2001 ; 67 (1). 86-91.
22. Deo S., Samaiya A., Jain P., et al. Sentinel lymph node biopsy assessment using intraoperative imprint cytology in breast cancer patients: results of a validation study. Asian J Surg. 2004 ; 27 (4). 294-298.
23. Derossis AM, Fey J., Yeung H., et al. A trend analysis of the relative value of blue dye and isotope localization in 2,000 consecutive cases of sentinel node biopsy for breast cancer. J Am Coll Surg. 2001 ; 193 (5). 473-478.
24. Fortunato L., Amini M., Farina M., et al. Intraoperative examination of sentinel nodes in breast cancer: is the glass half full or half empty? Ann Surg Oncol. 2004 ; 11 (11). 1005-1010.
25. Gillanders WE, Mikhitarian K., Hebert R., et al. Molecular detection of micrometastatic breast cancer in histopathology-negative axillary lymph nodes correlates with traditional predictors of prognosis: an interim analysis of a prospective multi-institutional cohort study. Ann Surg. 2004 ; 239 (6). 828-837.
26. Holck S., Galatius H., Engel U., et al. False-negative frozen section of sentinel lymph node biopsy for breast cancer. Breast. 2004 ;13(1): 42-48.
27. Litz CE, Beitsch PD, Roberts CA, et al. Intraoperative cytologic diagnosis of breast sentinel lymph nodes in the routine, nonacademic setting: a highly specific test with limited sensitivity. Breast J. 2004 ; 10 (5). 383-387.
28. Lockett MA, Baron PL, O'Brien PH, et al. Detection of occult breast cancer micrometastases in axillary lymph nodes using a multimarker reverse transcriptase-polymerase chain reaction panel. J Am Coll Surg. 1998 ; 187 (1). 9-16.
29. Motomura K., Inaji H., Komoike Y., et al. Intraoperative sentinel lymph node examination by imprint cytology and frozen sectioning during breast surgery. Br J Surg. 2000 ; 87 (5). 597-601.
30. Ouellette RJ, Richard D., Maicas E. RT-PCR for mammaglobin genes, MGB1 and MGB2, identifies breast cancer micrometastases in sentinel lymph nodes. Am J Clin Pathol. 2004 ; 121 (5). 637-643.
31. Ravichandran D., Kocjan G., Falzon M., et al. Imprint cytology of the sentinel lymph node in the assessment of axillary node status in breast carcinoma. Eur J Surg Oncol. 2004 ; 30 (3). 238-242.
32. Tabbara SO Sentinel lymph node: the role of intraoperative cytology. Pathol Case Rev. 2001 ; 6 (5). 191-195.
33. Wada N., Imoto S., Hasebe T., et al. Evaluation of intraoperative frozen section diagnosis of sentinel lymph nodes in breast cancer. Jpn J Clin Oncol. 2004 ; 34 (3). 113-117.
34. Weigelt B., Verduijn P., Bosma AJ, et al. Detection of metastases in sentinel lymph nodes of breast cancer patients by multiple mRNA markers. Br J Cancer. 2004 ; 90 (8). 1531-1537.
35. Weinberg ES, Dickson D., White L., et al. Cytokeratin staining for intraoperative evaluation of sentinel lymph nodes in patients with invasive lobular carcinoma. Am J Surg. 2004 ; 188 (4). 419-422.
36. Zgajnar J., Frkovic-Grazio S., Besic N., et al. Low sensitivity of the touch imprint cytology of the sentinel lymph node in breast cancer patients: results of a large series. J Surg Oncol. 2004 ; 85 (2). 82-86.
37. Hsu SM, Raine L., Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem. 1981 ; 29 (4). 577-580.
38. Dowlatshahi K., Fan M., Snider HC, et al. Lymph node micrometastases from breast carcinoma: reviewing the dilemma. Cancer. 1997 ; 80 (7). 1188-1197.
39. Huvos AG, Hutter Rvp, Berg JW Significance of axillary macrometastases and micrometastases in mammary cancer. Ann Surg. 1970 ; 173 (1). 44-46.
40. Mc Masters KM, Giuliano AE, Ross MI, et al. Sentinel-lymph-node biopsy for breast cancer: not yet the standard of care. N Engl J Med. 1998 ; 339 (14). 990-995.
41. Mc Masters KM, Wong SL, Chao C., et al. Defining the optimal surgeon experience for breast cancer sentinel lymph node biopsy: a model for implementation of new surgical techniques. Ann Surg. 2001 ; 234 (3). 292-300.
42. Sandrucci S., Casalegno PS, Percivale P., et al. Sentinel lymph node mapping and biopsy for breast cancer: a review of the literature relative to 4791 procedures. Tumori. 1999 ; 85 (6). 425-434.
43. Veronesi U., Zurrida S., Mazzarol G., et al. Extensive frozen section examination of sentinel nodes to determine selective axillary dissection. World J Surg. 2001 ; 25 (6). 806-808.
44. Cochran AJ Surgical pathology remains pivotal in the evaluation of "sentinel" lymph nodes. Am J Surg Pathol. 1999 ; 23 (10). 1169-1172.
45. Dowlatshakhi K., Fan M., Bloom KJ, et al. Occult metastases in the sentinel lymph nodes of patients with early stage breast carcinoma. Cancer. 1999 ; 86 (6). 990-995.
46. Cserni G. A model for determining the optimum histology of sentinel lymph nodes in breast cancer. J Clin Pathol. 2004 ; 57 (5). 467-471.
47. Czerniecki BJ, Scheff AM, Callans LS, et al. Immunohistochemistry with pancytokeratins improves the sensitivity of sentinel lymph node biopsy in patients with breast carcinoma. Cancer. 1999 ; 85 (5). 1098-1103.
48. Freneaux P., Nos C., Vincent-Salomon A., et al. Histological detection of minimal metastatic involvement in axillary sentinel nodes: a rational basis for a sensitive methodology usable in daily practice. Mod Pathol. 2002 ; 15 (6). 641-646.
49. Noguchi M. Current controversies concerning sentinel lymph node biopsy for breast cancer. Breast Cancer Res Treat. 2004 ; 84 (3). 261-271.
50. Silverberg SG Sentinel node processing: recommendations for pathologists. Am J Surg Pathol. 2002 ; 26 (3). 383-385.
51. Turner RR, Ollila DW, Stern S., et al. Optimal histopathologic examination of the sentinel lymph node for breast carcinoma staging. Am J Surg Pathol. 1999 ; 23 (3). 263-267.
52. Weaver DL Micrometastases in sentinel lymph nodes: pathologic aspects. Pathol Case Rev. 2003 ; 8 (5). 220-226.
53. Yared MA, Middleton LP, Smith TL, et al. Recommendations for sentinel lymph node processing in breast cancer. Am J Surg Pathol. 2002 ; 26 (3). 377-382.
54. Cserni G., Amendoeira I., Apostokilas N., et al. Discrepancies in current practice of pathological evaluation of sentinel lymph nodes in breast cancer: results of a questionnaire based survey by the European Working Group for Breast Screening Pathology. J Clin Pathol. 2004 ; 57 (7). 695-701.
55. Viale G., Sonzogni, Pruneri G, et al. Histopathologic examination of axillary sentinel lymph nodes in breast carcinoma patients. J Surg Oncol. 2004 ; 85 (3). 123-128.
56. Chiu A., Hoda SA, Yao DX, et al. A potential source of false-positive sentinel nodes: immunostain misadventure. Arch Pathol Lab Med. 2001 ; 125 (11). 1497-1499.
57. Diaz NM, Vrcel V., Centeno BA, et al. Modes of benign mechanical transport of breast epithelial cells of axillary lymph nodes. Adv Anat Pathol. 2005 ; 12 (1). 7-9.
58. Hoda SA, Resetkova E., Yusuf Y., et al. Megakaryocytes mimicking metastatic breast carcinoma. Arch Pathol Lab Med. 2002 ; 126 (5). 618-620.
59. Holdsworth PJ, Hopkinson JM, Leveson SH Benign axillary epithelial lymph node inclusions: a histological pitfall. Histopathology. 1988 ; 13 (2). 226-228.
60. Linden MD, Zarbo RJ Cytokeratin immunostaining patterns of benign reactive lymph nodes: applications for the evaluation of sentinel lymph node specimen. Appl Immunohistochem Molecul Morphol. 2001 ; 9 (4). 297-301.
61. Cserni G., Bianchi S., Boecker W., et al. Improving the reproducibility of diagnosis micrometastases and isolated tumor cells. Cancer. 2005 ; 103 (2). 358-367.
62. Diaz NM, Cox CE, Ebert M., et al. Benign mechanical transport of breast epithelial cells to sentinel lymph nodes. Am J Surg Pathol. 2004 ; 28 (12). 1641-1645.
63. Hansen NM, Ye X., Grube BJ, et al. Manipulation of the primary breast tumor and the incidence of sentinel node metastases from invasive breast cancer. Arch Surg. 2004 ; 139 (6). 634-639.
64. Klauber-DeMore N., Van Zee KJ, Linkov I., et al. Biological behavior of human breast cancer micrometastases. Clin Cancer Res. 2001 ; 7 (8). 2434-2439.
65. Lilleng PK, Mæhle BO, Hartveit F. The size of a micrometastasis in the axilla in breast cancer: a study of nodal tumour-load related to prognosis. Eur J Gynaecol Oncol. 1998 ; 20 (3). 220-224.
66. Mascarel I., Bonichon F., Coindre JM, et al. Prognostic significance of breast cancer axillary lymph node micrometastases assessed by two special techniques: reevaluation with longer follow-up. Br J Cancer. 1992 ; 66 (3). 523-527.
67. Noguchi M. Therapeutic relevance of breast cancer micrometastases in sentinel lymph nodes. Br J Surg. 2002 ; 89 (12). 1505-1515.
68. Peters-Engl C., Konstantiniuk P., Tausch C., et al. The impact of preoperative breast biopsy on the risk of sentinel lymph node metastases: analysis of 2502 cases from the Austrian Sentinel Node Biopsy Study Group. Br J Cancer. 2004 ; 91 (10). 1782-1786.
69. Poindexter NJ, Sahin A., Hunt KK, et al. Analysis of dendritic cells in tumor-free and tumor-containing sentinel lymph nodes from patients with breast cancer. Breast Cancer Res. 2004 ; 6 (4). 408-415.
70. Sakorafas GH, Geraghty J., Pavlakis G. The clinical significance of axillary lymph node micrometastases in breast cancer. Eur J Surg Oncol. 2004 ; 30 (8). 807-816.
71. Schrenk P., Hatzl-Griesenhofer M., Shamiyeh A., et al. Follow-up of sentinel node negative breast cancer patients without axillary lymph node dissection. J Surg Oncol. 2001 ; 77 (3). 165-170.
72. Weaver DL Sentinel lymph nodes and breast carcinoma: which micrometastases are clinically significant? Am J Surg Pathol. 2003 ; 27 (6). 842-845.